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Abstract 
Background: Few studies of breast cancer surgery outcomes have used longitudinal data for more than 2 years. This 
study aimed to validate the use of the artificial neural network (ANN) model to predict the 5‑year mortality of breast 
cancer patients after surgery and compare predictive accuracy between the ANN model, multiple logistic regression 
(MLR) model, and Cox regression model.
Methods: This study compared the MLR, Cox, and ANN models based on clinical data of 3632 breast cancer patients 
who underwent surgery between 1996 and 2010. An estimation dataset was used to train the model, and a validation 
dataset was used to evaluate model performance. The sensitivity analysis was also used to assess the relative signifi‑
cance of input variables in the prediction model.
Results: The ANN model significantly outperformed the MLR and Cox models in predicting 5‑year mortality, with 
higher overall performance indices. The results indicated that the 5‑year postoperative mortality of breast cancer 
patients was significantly associated with age, Charlson comorbidity index (CCI), chemotherapy, radiotherapy, hor‑
mone therapy, and breast cancer surgery volumes of hospital and surgeon (all P < 0.05). Breast cancer surgery volume 
of surgeon was the most influential (sensitive) variable affecting 5‑year mortality, followed by breast cancer surgery 
volume of hospital, age, and CCI.
Conclusions: Compared with the conventional MLR and Cox models, the ANN model was more accurate in predict‑
ing 5‑year mortality of breast cancer patients who underwent surgery. The mortality predictors identified in this study 
can also be used to educate candidates for breast cancer surgery with respect to the course of recovery and health 
outcomes.
Keywords: Breast cancer surgery, Artificial neural networks, Multiple logistic regression, Cox regression, 5‑year 
mortality
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Background
Breast cancer prevention is now a global health concern 
and is no longer limited to Western countries [1–3]. A 
2011 report released from the Department of Health, 
Taiwan, China indicated that breast cancer in women 
was the fourth most common cause of cancer-related 
deaths among Taiwan women and the mortality was 
increasing each year [4]. Therefore, exploring the factors 
affecting the 5-year mortality after breast cancer surgery 
is imperative.
Few studies have compared the artificial neural net-
work (ANN), multiple logistic regression (MLR), and Cox 
regression prediction models in terms of internal validity 
(reproducibility), which is an essential performance met-
ric [5, 6]. However, variable predictive models are insuffi-
cient to reliably predict the long-term survival of patients 
after surgery.
The ANN model used in the present study was a stand-
ard feed-forward, back-propagation neural network 
with three layers: an input layer, a hidden layer, and an 
output layer. A multilayer perceptron (MLP) network is 
an emerging tool for designing special classes of layered, 
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feed-forward networks [7]. The input layer comprises 
source neurons, and the output layer comprises outcome 
neurons; these two layers connect the network to the 
outside world. Additionally, an MLP network typically 
has one or more additional layers of neurons referred to 
as hidden neurons because they are not directly accessi-
ble. The hidden neurons extract important features con-
tained in the input data.
An MLP network is typically trained using a back-prop-
agation algorithm with forward and backward phases [7]. 
The back-propagation learning algorithm is easily imple-
mented, and its linear complexity in the synaptic weights 
of the network makes it computationally efficient. For 
optimal learning efficiency, the neurons are typically acti-
vated with both anti-symmetric functions (e.g., hyper-
bolic tangent function) and non-symmetric functions 
(e.g., logistic function). The following cross-validation 
technique is used to optimize the time when an MLP 
network training session “stops.” An estimation dataset 
is used for training the model, and a validation dataset is 
used for evaluating model performance. The neural net-
work is subsequently optimized using the training data-
set. Finally, a separate testing dataset is used to determine 
when training should stop to mitigate over-fitting. The 
training cycle is repeated until the testing error no longer 
decreases [8, 9].
Although substantially improved outcome prediction 
models have been developed for many surgical proce-
dures in recent years, studies of breast cancer outcome 
prediction models have had major shortcomings [10, 11]. 
For example, few studies have used longitudinal data for 
more than 2 years. Moreover, no breast cancer outcome 
prediction studies have considered group differences in 
factors such as age, gender, and non-surgical treatment. 
The present study used the ANN, MLR, and Cox models 
to identify the most influential factors for prediction of 
breast cancer surgery outcomes. The accuracy of various 
predictive models was also compared and analyzed using 
a global sensitivity analysis to assess the relative weights 
of significant predictors. The predictive simulations per-
formed in the present study are expected to improve 
healthcare policies in Taiwan, China and the develop-
ment of decision-supporting systems. Therefore, the pri-
mary aim of the present study was to validate the use of 
the ANN model for predicting 5-year mortality of breast 
cancer patients after surgery. The secondary aim was to 
compare predictive capability between the ANN, MLR, 
and Cox models.
Patients and methods
Study design and study population
In the present study, we applied a longitudinal research 
design based on a retrospective cohort study of patients 
who had undergone breast cancer surgery between Janu-
ary 1, 1996 and December 31, 2010 in Taiwan, China. The 
inclusion criteria were patients older than 18 years, who 
had received breast cancer surgery, and who were iden-
tified by database searches using ICD-9-CM 174.× diag-
nosis codes 174.0–174.9 and procedure codes 85.20–23, 
85.33–36, 85.4×, 85.5×, 85.6×, 85.7×, 85.8×, and 85.95.
Data collection
The present study analyzed data obtained from “the 
Bureau of National Health Insurance (BNHI)” in Taiwan, 
China. The BNHI database provided detailed administra-
tive data regarding healthcare services, including outpa-
tient visits, hospitalizations, and prescriptions, and has 
become extremely comprehensive [12]. The Longitudinal 
Health Insurance Database for year 2005 was established 
using a random sample with one million beneficiaries 
of all residents aged ≥18 years enrolled in the “National 
Health Insurance” program. The data source in this ret-
rospective study was “the National Health Insurance 
Research Database” in Taiwan, China.
Ethical considerations
The present study, which solely analyzed aggregate sec-
ondary data without identifying specific patients, was 
exempt from full review by the internal review board of 
Kaohsiung Medical University Hospital. Nevertheless, 
the study protocol still conformed to the ethical stand-
ards established with the 1964 Declaration of Helsinki, 
which waived the requirement for written or verbal 
patient consent in data linkage studies.
Potential confounders
The research variables were categorized into patient and 
hospital characteristics based on the research covariates. 
The patient characteristics comprised age, comorbid-
ity (circulatory system comorbidity and genitourinary 
system comorbidity), and treatment methods (chemo-
therapy, radiotherapy, and hormone therapy). Breast can-
cer surgery type was categorized as breast-conserving 
surgery, modified radical mastectomy, and mastectomy 
with reconstruction. Comorbidities identified according 
to ICD-9-CM codes for primary and secondary diagno-
ses were used to calculate Charlson comorbidity index 
(CCI) [13]. The hospital characteristics were surgery vol-
umes of hospital and surgeon, and hospital level. For each 
hospital or surgeon, the surgery volume was defined as 
the number of breast cancer surgeries performed by the 
respective hospital or surgeon each year. Hospital level 
was recorded as medical center (>500 beds), regional 
hospital (301–500 beds), or district hospital (<300 beds) 
according to accreditation by the Taiwan Joint Commis-
sion on Hospital Accreditation.
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The database was randomly separated into three data-
sets for training, testing, and external validation in a 
7:2:1 ratio. In a probabilistic view of neural networks, 
this randomization can be viewed as a form of statistical 
sampling, such as Monte Carlo sampling. Once the opti-
mization algorithm reached a certain level of precision, 
the stability and generalizability of the results obtained 
with a given ANN should be investigated using a jack-
knife validation [14].
Statistical analysis
The unit of analysis in the present study was the indi-
vidual patient who underwent breast cancer surgery. The 
primary analytical methods were descriptive and inferen-
tial statistical analyses. The descriptive analyses had two 
objectives: (1) to describe the distribution of continu-
ous variables using mean ± standard deviation (SD) and 
median in interquartile range (IQR); and (2) to describe 
the distribution of categorical variables using the number 
of total samples (N) and percentage (%). The inferential 
analysis comprised univariate and multivariate analyses 
using the ANN, MLR, and Cox models. The independ-
ent variables were age, CCI, surgery type, circulatory 
system comorbidity, genitourinary system comorbidity, 
chemotherapy, radiotherapy, hormone therapy, hospital 
level, surgery volumes of hospital and surgeon, and the 
dependent variable was the 5-year mortality of breast 
cancer patients after surgery. The discriminatory power 
of the models was also analyzed using the area under the 
receiver operating characteristic curves (AUC). Here, dis-
criminatory power refers to the ability of a model to dis-
tinguish individuals who died from those who survived. 
A perfectly discriminatory model would assign a higher 
probability of death to patients who died than to patients 
who survived. For categorical variables, an overall test 
was applied to calculate the global P value, ensuring that 
the assumption of proportional hazards was not violated, 
and to identify any time-varying covariates.
The sensitivity analysis was performed to assess the 
importance of variables in the prediction models. The 
training process was simplified by introducing key vari-
ables and excluding all unnecessary variables. The sen-
sitivity analysis was also performed to assess the relative 
significance of input variables in the prediction model 
and to rank the variables according to the order of impor-
tance. The sensitivity of the input variables against the 
output variables was expressed as the ratio of the net-
work error (sum of squared residuals). A variable sensi-
tivity ratio (VSR) of 1 or lower indicates that the variable 
diminishes network performance and should be removed.
The SPSS Version 20.0 statistical software (IBM SPSS 
Inc., Chicago, IL, USA) was used for statistical analyses.
Results
Patient selection
In total, 4151 patients underwent surgery for breast can-
cer during the study period. Among them, 519 patients 
were excluded, and 3632 were included for subsequent 
analyses (Fig.  1). The overall database was randomly 
divided into a model training dataset of 2543 cases, a 
model testing dataset of 726 cases, and a model validation 
dataset of 363 cases. The jack-knife method confirmed 
that the correlation between the classification probabili-
ties of the prediction and the jack-knife validation was 
R = 0.93, suggesting a good stability of the results.
Study characteristics
Table  1 shows the clinical and hospitalization charac-
teristics of the patients analyzed in the present study. 
The median age of the patients was 52  years (IQR, 
24–87  years). The median CCI was 1 (IQR, 0–1), and 
the occurrence rates of circulatory system and geni-
tourinary system comorbidities were 7.8% and 6.5%. 
The median breast cancer surgery volume was 57 (IQR, 
14–68) for hospitals and 14 (IQR, 4–29) for surgeons. 
Chemotherapy, radiotherapy, and hormone ther-
apy were received by 41.8%, 11.0%, and 71.4% of the 
patients, respectively.
Table 2 shows the coefficients for 5-year mortality of 
the training dataset in the MLR model. The multivari-
ate analysis results indicated that the 5-year mortality 
of breast cancer patients was significantly associated 
with age, CCI, chemotherapy, radiotherapy, hormone 
therapy, and breast cancer surgery volumes of hospital 
and surgeon (global P  <  0.05). These significant varia-
bles were therefore included into these three prediction 
models.
Comparisons between these three models
The difference in the 5-year postoperative mortality of 
breast cancer patients between the training and testing 
datasets was not significant (data not shown). Therefore, 
samples from these two datasets could be compared to 
enhance the reliability of the validation results. The ANN 
model was also used to obtain the 3-layer network and 
the relative weights of neurons for the prediction of the 
5-year mortality. The MLP network includes 7 input neu-
rons, 1 bias neuron in the input layer, 4 hidden neurons, 
1 bias neuron in the hidden layer, and 2 output neurons 
(Fig. 2).
Comparisons of samples in the training, testing, and 
validation datasets showed that the ANN model signifi-
cantly outperformed the MLR and COX models in terms 
of sensitivity, specificity, positive predictive value, nega-
tive predictive value, accuracy, and AUC (Table 3).
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Significant predictors in the ANN model
The training dataset was also used to calculate the VSRs 
for the MLP network. The global sensitivity analysis 
showed that the most sensitive variable for predicting 
5-year mortality was breast cancer surgery volume of 
surgeon (VSR = 1.16), followed by breast cancer surgery 
volume of hospital (VSR = 1.14), age (VSR = 1.08), and 
CCI (VSR  =  1.06). All VSR values exceeded 1, indicat-
ing that the network performed better when all variables 
were considered.
Discussion
Performance indices were used to compare the three 
models in terms of accuracy in predicting breast cancer 
patient mortality. Overall, the mortality predicted using 
the ANN model was considerably more accurate than 
those predicted using the MLR and Cox models. When 
using actual outcome data for a performance comparison 
based on a simple outcome measure such as mortality, 
the ANN model clearly outperformed the MLR and Cox 
models constructed using the same limited number of 
clinical inputs.
Compared with reports that used data from a single 
medical center, the present registry study based on the 
data from BNHI, Taiwan, China provides a better over-
view of the current practice of breast cancer surgery. 
Unlike other single-center serial studies, the data from 
the present study and previous registry studies [15–17] 
provide an overview of the practices in large populations, 
avoiding referral bias or bias reflecting the practices of 
individual surgeons or institutions.
In recent years, studies have consistently shown that 
the ANN prediction model was superior to the MLR and 
Cox models [18–20]. Statistical analyses have also con-
firmed the advantages and preferred characteristics of the 
ANN model. The high fault tolerance of the ANN model 
also facilitates the appropriate and accurate process-
ing of incomplete or noise-added inputs [13]. Moreover, 
highly correlated and non-normally distributed data can 
be used to construct linear and non-linear ANN models 
Patients hospitalized after a principal 
diagnosis of breast cancer (ICD-9-CM codes 
174.x) during 1996-2010 (n = 6426) 
Patients who underwent surgery for breast 
cancer (ICD-9-CM procedure codes 
85.20-23, 85.33-36, 85.4x, 85.5x, 85.6x, 85.7x, 
85.8x, and 85.95; n = 4151) 
Excluded: 
1. Patients who underwent repeated breast 
cancer surgery (n = 514) 
2. Patients less than 18 years old (n = 1) 
3. Male patients (n = 1) 
4. Patients of unknown gender (n = 3) 
Eligible patients  
(n = 3632) 
Fig. 1 Flowchart of the study procedure
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with broad applications in large-scale medical databases. 
In the medical field, the ANN model is commonly used 
for clinical research, especially for prognosis prediction 
[18–20]. Comparisons of various models in the present 
study suggested that the ANN predictive model was 
superior for expanding predictor variables to facilitate 
the systematic analysis of various diseases, for evaluating 
the effectiveness of research methods, and for compre-
hensively predicting mortality. The established predictive 
model can also be extended to other cancer types.
We conducted a global sensitivity analysis to assess the 
weights of significant predictors affecting the 5-year post-
operative mortality of breast cancer patients. We found 
that surgery volume of surgeon was the most important 
predictor of 5-year mortality of breast cancer patients, 
consistent with the results of other reports [21, 22] show-
ing that surgeons with high surgery volumes consist-
ently achieve superior outcomes of breast cancer surgery 
than surgeons with low surgery volumes. Therefore, the 
treatment strategies made by these surgeons should be 
carefully analyzed and emulated. If the 5-year mortality 
is considered a benchmark, then breast cancer surgery 
volume of surgeon, a major predictor of postoperative 
outcomes, is crucial. Clearly, the outcomes of surgical 
procedures depend not only on clinical management but 
also on the skill and experience of individual surgeons. 
Moreover, surgeons with high surgery volumes in hospi-
tals with high surgery volumes are most likely to achieve 
good patient outcomes because they are well supported 
by highly skilled interdisciplinary care teams [21].
Breast cancer surgery volumes of surgeon and hospi-
tal are the selection criteria typically considered by indi-
viduals seeking healthcare services. Patients also tend to 
seek treatment at large medical centers and by renowned, 
authoritative physicians [21, 22]. The results of the pre-
sent study indicated that the surgery volumes of surgeon 
and hospital were negatively correlated with the 5-year 
mortality of breast cancer patients. That is, compared 
with their counterparts with low surgery volumes, hos-
pitals and surgeons with high surgery volumes achieved 
higher patient survival rates. This finding provides a 
reference for healthcare institutions when assisting sur-
geons in cultivating relevant surgical experience.
The positive correlation observed between breast can-
cer mortality and age at onset requires further study. 
Strategies for improving screening rates to achieve early 
detection and treatment should also be investigated and 
compared. These data would provide a valuable reference 
for screening and for integrating therapeutic methods in 
predictive models for medical decision making.
Patients who undergo surgery for breast cancer are 
often burdened by cancer-related comorbidities that 
increase the risk of poor surgical outcomes, such as long 
hospitalization, high mortality, and high treatment costs 
[18–22]. In the present study, the statistical data for post-
operative outcomes also revealed that 5-year mortality 
increased with CCI.
This long-term follow-up study analyzed patient data 
obtained from a database in Taiwan, China. In addition 
to enhancing the variance analysis of the correlation 
between treatment and survival, predictive models also 
have many applications in clinical care. The methods 
developed in the present study can also be used at health-
care institutions to evaluate the effectiveness of screening 
methods for early detection and treatment. Because of its 
accuracy in predicting breast cancer mortality, the pro-
posed ANN model can be used to provide further data 
supporting the consensus view regarding the importance 
of breast cancer screening and the need for prompt and 
appropriate action. Beyond breast cancer, broader appli-
cations of this method can also facilitate the formulation 
and promotion of healthcare policies and the develop-
ment of decision-supporting systems in Taiwan, China, 
Table 1 Clinical and  hospitalization characteristics of  the 
3632 selected patients who underwent surgery for breast 
cancer
Variable Number of patients (%)
Breast cancer surgery type
 Breast‑conserving surgery 1110 (30.6)
 Modified radical mastectomy 2248 (61.9)
 Mastectomy with reconstruction 274 (7.5)
Circulatory system comorbidity
 No 3347 (92.2)
 Yes 285 (7.8)
Genitourinary system comorbidity
 No 3396 (93.5)
 Yes 236 (6.5)
Chemotherapy
 No 2114 (58.2)
 Yes 1518 (41.8)
Radiotherapy
 No 3233 (89.0)
 Yes 399 (11.0)
Hormone therapy
 No 1037 (28.6)
 Yes 2595 (71.4)
Hospital level
 Medical center 2109 (58.1)
 Regional hospital 1341 (36.9)
 District hospital 182 (5.0)
5‑year outcome after surgery
 Death 502 (13.8)
 Survival 3130 (86.2)
Page 6 of 9Huang et al. Chin J Cancer  (2017) 36:23 
which would ultimately enhance the health of all citizens. 
Additional studies are needed to determine the true clini-
cal relevance of the ANN model and to clarify whether 
clinicians can effectively use the model to predict prog-
nosis and optimize the surgical management for patients.
The present study has several limitations inherent in 
any large database analysis. First, the clinical picture 
obtained in the analysis of claims data is not as precise as 
that obtained in the analysis of a prospective clinical trial 
data, reflecting potential errors in the coding of primary 
diagnoses and surgical modalities. Second, complications 
associated with breast cancer surgical procedures were 
not assessed, limiting the validity of the comparison. 
Third, the specific focus on 5-year mortality as the end-
point of this prediction tool may limit the overall clinical 
use of the ANN model to a small subset of patients who 
have a high likelihood of death within 5  years. Fourth, 
only three models were used to predict 5-year survival 
after breast cancer surgery. Finally, other outcomes, such 
as patient-reported quality of life, were not compared 
because the relevant data were not included in the data-
base. However, considering the robust magnitude and the 
statistical significance of the effects in the present study, 
these limitations are unlikely to compromise the validity 
of the results.
Conclusions
Compared with the conventional MLR and Cox models, 
the ANN model in the present study was more accurate 
in predicting 5-year mortality of patients after breast 
Table 2 The analysis of  the relationship between  effective predictors and  5-year mortality of  the 2543 breast cancer 
patients using the multiple logistic regression (MLR) model
OR odds ratio, 95% CI 95% confidence interval, MRM modified radical mastectomy, BCS breast-conserving surgery, TRAM transverse rectus abdominis myocutaneous 
flap reconstruction. Surgery volume of hospital/surgeon was defined as the percentage of breast cancer surgeries among the total surgeries performed by the 
respective hospital or surgeon during the study period
Variable Univariate analysis Multivariate analysis
OR (95% CI) P value OR (95% CI) P value
Age 1.02 (1.02–1.03) 0.001 1.03 (1.03–1.04) 0.001
Charlson comorbidity index 1.18 (1.14–1.22) 0.001 1.15 (1.11–1.20) 0.001
Circulatory system comorbidity
 Yes vs. no 1.08 (0.77–1.53) 0.641 0.89 (0.62–1.28) 0.543
Genitourinary system comorbidity
 Yes vs. no 0.76 (0.50–1.15) 0.198 0.84 (0.54–1.30) 0.441
Breast cancer surgery type
 MRM vs. BCS 1.04 (0.97–1.12) 0.247 1.03 (0.95–1.12) 0.448
 MRM + TRAM vs. BCS 1.02 (0.98–1.06) 0.475 1.01 (0.98–1.04) 0.790
Chemotherapy
 Yes vs. no 1.57 (1.30–1.90) 0.001 1.92 (1.55–2.38) 0.001
Radiotherapy
 Yes vs. no 1.46 (1.11–1.92) 0.006 1.52 (1.13–2.05) 0.006
Hormone therapy
 Yes vs. no 0.74 (0.59–0.92) 0.006 0.79 (0.68–0.90) 0.006
Hospital level
 Medical center vs. district hospital 0.98 (0.94–1.02) 0.276 0.98 (0.95–1.02) 0.161
 Regional hospital vs. district hospital 0.94 (0.86–1.03) 0.149 0.95 (0.89–1.02) 0.092
Surgery volume of hospital 0.94 (0.92–0.96) 0.001 0.95 (0.92–0.98) 0.004
Surgery volume of surgeon 0.93 (0.91–0.96) <0.001 0.93 (0.90–0.97) <0.001
(See figure on next page.) 
Fig. 2 Schematic representation of the artificial neural network (ANN) model. This model consists of 7 input neurons [age, Charlson comorbidity 
index (CCI), chemotherapy, radiotherapy, hormone therapy, surgery volumes of hospital and surgeon], 1 bias neuron in the input layer, 4 neurons in 
a single hidden layer (H1‑4), 1 bias neuron in the hidden layer (HB), and 2 output neurons (death and survival) representing the 5‑year outcome of 
breast cancer patients after surgery. Surgery volume of hospital/surgeon was defined as the percentage of breast cancer surgeries among the total 
surgeries performed by the respective hospital or surgeon during the study period
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cancer surgery and showed higher overall performance 
indices. The predictors analyzed in the present study 
could be addressed in preoperative and postopera-
tive health care consultations to educate candidates for 
breast cancer surgery in the expected course of recov-
ery and health outcomes. The international academic 
community has commended the researchers in Taiwan, 
China for the novel findings obtained by database stud-
ies. However, these studies can be further improved by 
including additional clinical variables, which could yield 
additional research findings and increase precision. Such 
findings can therefore provide a vital and indicative basis 
for promoting healthcare policies in Taiwan, China.
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Testing dataset (n = 726)
 ANN model 88.00 89.04 77.52 87.64 88.50 71.67
 MLR model 83.00 84.36 73.35 87.02 86.09 51.93
 Cox model 86.43 87.57 74.99 87.10 86.45 65.87
Validation dataset (n = 363)
 ANN model 85.66 88.71 53.42 86.89 88.82 70.76
 MLR model 83.77 87.35 50.96 86.01 85.40 52.44
 Cox model 84.61 85.43 52.02 86.60 86.91 64.79
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